Publication | Closed Access

Combined use of 123I-metaiodobenzylguanidine (MIBG) scintigraphy and dopamine transporter (DAT) positron emission tomography (PET) predicts prognosis in drug-induced Parkinsonism (DIP): A 2-year follow-up study

Positron Emission TomographyNeuro-oncologyDopamine TransporterParkinson DiseaseMedicineNeuroimagingNeurologyNeuroscienceDrug-induced ParkinsonismDopaminePharmacologyNuclear Medicine